D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

The oncoproteins MDM2 and MDMX negatively regulate the activity and stability of the tumor suppressor protein p53, conferring tumor development and survival. Antagonists targeting the p53-binding domains of MDM2 and MDMX kill tumor cells both in vitro and in vivo by reactivating the p53 pathway, pro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Liu, Min, Li, Chong, Pazgier, Marzena, Li, Changqing, Mao, Yubin, Lv, Yifan, Gu, Bing, Wei, Gang, Yuan, Weirong, Zhan, Changyou, Lu, Wei-Yue, Lu, Wuyuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2010
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922601/
https://ncbi.nlm.nih.gov/pubmed/20660730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1008930107
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak